Detalhe da pesquisa
1.
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
BJU Int
; 115(5): 764-71, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24988879
2.
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis.
Immunotherapy
; 15(2): 117-126, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695110
3.
Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.
Eur Urol
; 68(1): 147-53, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25457020
4.
Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger.
Urol Oncol
; 33(6): 265.e15-21, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25907622